Table 1. Clinical characteristics of participants from GS2 and GHS-prospective design.
| GS2 (n = 280) | GHS (n = 359) | |
|---|---|---|
| Sex (M/F) | 224/56 | 242/117 |
| Age (yrs) | 42.8 ± 11.4 | 64.4 ± 8.1 |
| BMI (Kg/m2) | 27.1 ± 3.5 | 30.2 ± 4.8 |
| Waist circumference (cm) | 93.9 ± 10.6 | NA |
| HOMAIR | 2.0 ± 1.6 | NA |
| Triglycerides (mg/dl) | 130.4 ± 94.2 | 152.6 ± 91.8 |
| HDL-Cholesterol (mg/dl) | 50.4 ± 11.0 | 43.6 ± 14.6 |
| SBP (mm Hg) | 125.6 ± 10.8 | 134.9 ± 19.1 |
| DPB (mm Hg) | 79.8 ± 6.7 | 76.4 ± 9.8 |
| Smokers (%) | NA | 64 (17.8) |
| Diabetes duration (yrs) | NA | 13.8 ± 9.2 |
| HbA1C (% and mmol/mol) | NA | 8.6 ± 1.9 and 70.8 ± 20.6 |
| Insulin w or w/o oral agents (%) | NA | 194 (54.0) |
| Anti-hypertension therapy (%) | NA | 305 (85.0) |
| Anti-dyslipidemia therapy (%) | NA | 233 (64.9) |
| hsCRP (mg/L) | NA | 1.4 (0.7–5.5) |
Continuous variables were reported as mean ± SD, whereas categorical variables as total frequency.
GS2: Gargano Study 2; M: males; F: females; BMI: body mass index; HOMAIR: Homeostatic model assessment of insulin resistance; SBP: systolic blood pressure; DBP: diastolic blood pressure. HbA1c: glycated haemoglobin A1C; hsCRP: high sensitive C reactive protein. NA: not applicable.